Cancer Cells Generate Frequent Genetic Mutations
New research shows cancer cells create up to five new chromosomal alterations per cycle, complicating tumor evolution.
Updated on Oct. 22, 2026 in Cancer
Researchers using single genome sequencing have identified that cancer cells generate one to five new chromosomal copy number alterations during each cell cycle. This experimental study tracks how genomic instability drives tumor complexity across five different cancer types.
Why it matters
Understanding how rapidly cancer cells mutate helps researchers map the drivers of genomic complexity. These findings illustrate the persistent challenge of tumor evolution when facing treatment pressure.
In an experimental study tracking 34 cancer cell lines and organoids, researchers identified that chromosomal instability generates one to five new copy number alterations per cell cycle. This research indicates that these mutations are stochastically distributed, with whole genome duplication events further increasing these instability rates.
The details
Using single genome sequencing, researchers tracked the evolution of cancer genomes to observe how they change under chemotherapy selection pressure. The study covered five cancer types, including high-grade serous ovarian carcinoma, pancreatic ductal adenocarcinoma, colorectal cancer, breast cancer, and sarcoma. These findings suggest that the continuous generation of copy number alterations is a fundamental driver of genomic complexity within tumors.
Timeline
The study findings were published in October 2026.
Health Landscape
This research provides a dynamic look at mutation rates that complements the static genomic maps established by the Cancer Genome Atlas research program. It highlights how cellular instability persists as a core factor in tumor evolution across diverse cancer types.
While this laboratory study does not change immediate treatment protocols, it underscores why cancer care often requires monitoring for shifting tumor characteristics. Patients undergoing active cancer treatment should discuss the significance of genomic testing and tumor evolution with their oncology team.
The takeaway
Cancer cells exhibit persistent chromosomal instability that leads to multiple new genetic alterations every time they divide. Readers should consult with their physicians about how tumor genomic testing can inform personalized care decisions during treatment.
Further reading
For more information on how researchers track tumor development, visit our Cancer section.
More information
View the study on chromosomal instability in cancer for technical data.
Source note: This article includes information reported by Biorxiv.
